+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 152 Pages
  • June 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5948222
Description Jump to:
The global biological drugs market is on a robust growth trajectory, driven by increasing demand for effective treatments for chronic diseases such as cancer, severe blood disorders, and autoimmune diseases. Unlike conventional drugs, biological drugs are derived from living cells, making them more complex and specialized. The rising prevalence of chronic diseases worldwide has spurred demand for these advanced therapies. According to Fairfield Market Research the global biological drugs market is projected to grow at a healthy CAGR of over 10% during the forecast period.

Key Market Dynamics

The demand for biological drugs is anticipated to surge in the near future, largely due to the growing geriatric population and the increasing incidence of chronic diseases globally. Additionally, various healthcare awareness initiatives led by both public and private organizations are further propelling market growth. Innovations in biomedical technology and ongoing R&D programs are expected to uncover new opportunities for market expansion.

However, the market faces challenges such as patent expirations of bestselling drugs and the high costs associated with biological drugs. Moreover, the risk of severe side effects and complications related to injectable biological drugs may also hinder market growth.

Regional Analysis

Geographically, the global biological drugs market is segmented into North America, Asia Pacific, Europe, and the rest of the world (RoW). North America is expected to remain the most lucrative market for biological drugs during the forecast period. The increasing demand for biological drugs to treat diabetes and cancer, coupled with frequent healthcare awareness programs conducted by public organizations, is driving market growth in the region.

In Europe, the market is primarily driven by the demand for biological drugs from the region's aging population. According to a UN report, the elderly population in Germany is expected to constitute 33.2% of the country's total population. In Asia, government initiatives and substantial funding for new biotech companies, drug manufacturing facilities, and life science institutions are expected to stimulate market growth. Additionally, lower drug manufacturing costs in Asia attract overseas companies to establish manufacturing plants in the region.

Key Market Participants

Several key players dominate the global biological drugs market, including:

  • Merck & Co., Inc.
  • Abbott Laboratories
  • Eli Lilly and Company
  • Baxter International Inc.
  • Novartis AG
  • Pfizer Inc.
  • Biogen Idec
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • GlaxoSmithKline plc

Market Segmentation

The market is segmented based on therapeutic protein, monoclonal antibodies (mAb), and vaccines.

By Therapeutic Protein:

  • Enbrel
  • Lantus
  • Neulasta
  • Avonex
  • NovoLog
  • Rebif
  • Humalog
  • Aranesp
  • Epogen
  • Levemir
  • Victoza
  • Betaseron
  • Neupogen
  • Eylea

By mAb:

  • Humira
  • Remicade
  • Rituxan
  • Avastin
  • Herceptin
  • Lucentis

By Vaccine:

  • Prenvar 13
  • Gardasil
  • Fluzone
  • Varivax
  • Cervarix

By Geography:

  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Biological Drugs Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Biological Drugs Market Outlook, 2018 - 2031
3.1. Global Biological Drugs Market Outlook, By Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Monoclonal Antibodies
3.1.1.2. Vaccines
3.1.1.3. Therapeutic Enzymes
3.1.1.4. Others
3.2. Global Biological Drugs Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Infectious Diseases
3.2.1.2. Oncology
3.2.1.3. Cardiovascular Diseases
3.2.1.4. Immunological Disorders
3.2.1.5. Others
3.3. Global Biological Drugs Market Outlook, By Mode of Purchase, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Prescription Drugs
3.3.1.2. Over-the-Counter Drugs
3.4. Global Biological Drugs Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Hospital Pharmacies
3.4.1.2. Retail Pharmacies
3.4.1.3. Online Pharmacies
3.5. Global Biological Drugs Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Biological Drugs Market Outlook, 2018 - 2031
4.1. North America Biological Drugs Market Outlook, By Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Monoclonal Antibodies
4.1.1.2. Vaccines
4.1.1.3. Therapeutic Enzymes
4.1.1.4. Others
4.2. North America Biological Drugs Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Infectious Diseases
4.2.1.2. Oncology
4.2.1.3. Cardiovascular Diseases
4.2.1.4. Immunological Disorders
4.2.1.5. Others
4.3. North America Biological Drugs Market Outlook, By Mode of Purchase, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Prescription Drugs
4.3.1.2. Over-the-Counter Drugs
4.4. North America Biological Drugs Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Hospital Pharmacies
4.4.1.2. Retail Pharmacies
4.4.1.3. Online Pharmacies
4.5. North America Biological Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Biological Drugs Market Outlook, 2018 - 2031
5.1. Europe Biological Drugs Market Outlook, By Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Monoclonal Antibodies
5.1.1.2. Vaccines
5.1.1.3. Therapeutic Enzymes
5.1.1.4. Others
5.2. Europe Biological Drugs Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Infectious Diseases
5.2.1.2. Oncology
5.2.1.3. Cardiovascular Diseases
5.2.1.4. Immunological Disorders
5.2.1.5. Others
5.3. Europe Biological Drugs Market Outlook, By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Prescription Drugs
5.3.1.2. Over-the-Counter Drugs
5.4. Europe Biological Drugs Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Hospital Pharmacies
5.4.1.2. Retail Pharmacies
5.4.1.3. Online Pharmacies
5.5. Europe Biological Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.17. Türkiye Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
5.5.1.18. Türkiye Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.19. Türkiye Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.5.1.20. Türkiye Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biological Drugs Market Outlook, 2018 - 2031
6.1. Asia Pacific Biological Drugs Market Outlook, By Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Monoclonal Antibodies
6.1.1.2. Vaccines
6.1.1.3. Therapeutic Enzymes
6.1.1.4. Others
6.2. Asia Pacific Biological Drugs Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Infectious Diseases
6.2.1.2. Oncology
6.2.1.3. Cardiovascular Diseases
6.2.1.4. Immunological Disorders
6.2.1.5. Others
6.3. Asia Pacific Biological Drugs Market Outlook, By Mode of Purchase, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Prescription Drugs
6.3.1.2. Over-the-Counter Drugs
6.4. Asia Pacific Biological Drugs Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Hospital Pharmacies
6.4.1.2. Retail Pharmacies
6.4.1.3. Online Pharmacies
6.5. Asia Pacific Biological Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biological Drugs Market Outlook, 2018 - 2031
7.1. Latin America Biological Drugs Market Outlook, By Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Monoclonal Antibodies
7.1.1.2. Vaccines
7.1.1.3. Therapeutic Enzymes
7.1.1.4. Others
7.2. Latin America Biological Drugs Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Infectious Diseases
7.2.1.2. Oncology
7.2.1.3. Cardiovascular Diseases
7.2.1.4. Immunological Disorders
7.2.1.5. Others
7.3. Latin America Biological Drugs Market Outlook, By Mode of Purchase, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Prescription Drugs
7.3.1.2. Over-the-Counter Drugs
7.4. Latin America Biological Drugs Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Hospital Pharmacies
7.4.1.2. Retail Pharmacies
7.4.1.3. Online Pharmacies
7.5. Latin America Biological Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biological Drugs Market Outlook, 2018 - 2031
8.1. Middle East & Africa Biological Drugs Market Outlook, By Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Monoclonal Antibodies
8.1.1.2. Vaccines
8.1.1.3. Therapeutic Enzymes
8.1.1.4. Others
8.2. Middle East & Africa Biological Drugs Market Outlook, By Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Infectious Diseases
8.2.1.2. Oncology
8.2.1.3. Cardiovascular Diseases
8.2.1.4. Immunological Disorders
8.2.1.5. Others
8.3. Middle East & Africa Biological Drugs Market Outlook, By Mode of Purchase, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Prescription Drugs
8.3.1.2. Over-the-Counter Drugs
8.4. Middle East & Africa Biological Drugs Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Hospital Pharmacies
8.4.1.2. Retail Pharmacies
8.4.1.3. Online Pharmacies
8.5. Middle East & Africa Biological Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Biological Drugs Market By Product, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Biological Drugs Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Biological Drugs Market By Mode of Purchase, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Biological Drugs Market By Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2024
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. Roche Diagnostics
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. AstraZeneca
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Bayer AG
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. GSK Biologicals
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Samsung BioLogics
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. F Hoffmann-La Roche, Ltd.
9.3.7.1. Company Overview
9.3.7.2. Product Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Eli Lilly and Company
9.3.8.1. Company Overview
9.3.8.2. Product Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Merck & Co., Inc.
9.3.9.1. Company Overview
9.3.9.2. Product Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Pfizer Inc.
  • Abbott Laboratories.
  • Novartis AG.
  • Eli Lilly and Company.
  • GlaxoSmithKline plc.
  • Bristol-Myers Squibb Company.
  • Merck & Co., Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Biogen Idec.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biological Drugs - Global Strategic Business Report - Product Image

Biological Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Biological Drug API Manufacturing Services Market Report 2023-2033 - Product Image

Biological Drug API Manufacturing Services Market Report 2023-2033

  • Report
  • 261 Pages
  • Global
From
Biological Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Biological Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 90 Pages
  • Global
From
Dermatology Biologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Dermatology Biologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
From
Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 106 Pages
  • Global
Copyright © 2002-2024 Research and Markets. All Rights Reserved.